CYTL1 Protein, Human (114a.a, HEK293, Fc)

CYTL1 protein is specifically expressed in CD34+ hematopoietic cells, indicating that it exists selectively in this hematopoietic cell subpopulation. This targeted expression pattern suggests a potential role in maintaining or differentiating CD34+ cells, emphasizing the importance of CYTL1 in the complex molecular processes that control blood cell development. CYTL1 Protein, Human (114a.a, HEK293, Fc) is the recombinant human-derived CYTL1 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CYTL1 Protein, Human (114a.a, HEK293, Fc) is 114 a.a., with molecular weight of 50-55 kDa.

CYTL1 protein exhibits specific expression in CD34+ hematopoietic cells, indicating its selective presence within this subset of cells involved in the regulation of hematopoiesis. This targeted expression pattern suggests a potential role for CYTL1 in the maintenance or differentiation of CD34+ hematopoietic cells, emphasizing its significance within the intricate network of molecular processes governing blood cell development and homeostasis. The specific association of CYTL1 with CD34+ cells implies a potential involvement in hematopoietic stem or progenitor cell functions, further underscoring its relevance in the finely tuned mechanisms of hematopoiesis.

Human

HEK293

C-hFc

Q9NRR1 (T23-R136)

54360  [NCBI]

50-55 kDa

Greater than 95% as determined by Tris-Bis PAGE.

<1 EU/μg, determined by LAL method.